Injectable Drug Delivery Resources

1. Maintaining Superior Viral Vector Recovery In Cell And Gene Therapy Applications 9/3/2024

   A study assessing the stability of vials aimed to determine if the vial material had any influence on the viral titer and particle counts of the AAV serotypes.

2. Maintaining Sterility Through Precise Component Design And Manufacture 4/21/2026

   Prioritizing high-quality component design and manufacturing excellence can mitigate risks, ensure long-term container closure integrity, and avoid the costly delays associated with non-compliance.

3. A Lifecycle Management Strategy For Sterile Injectables 12/9/2022

   Gain insight into the benefits and challenges of transferring a therapeutic compound from one aseptic injectable format to another.

4. Stopper Functionality – Key Considerations

   When selecting the appropriate rubber stopper for any respective vial containment system, there are many aspects to consider regarding the properties of the elastomeric closure.

5. De-Risking FDA Abbreviated New Drug Application (ANDA) Submissions 6/26/2025

   BD’s Vystra™ Disposable Pen for Liraglutide 3.0 mg demonstrated comparable usability to the reference device, helping de-risk ANDA submissions through proactive human factors evaluation.

6. Rational Design And Development Of Long-Acting Injectable Dosage Forms 1/26/2022

   The increasing prevalence of chronic disorders, growing demand for self-administration, and the increasing demand for minimally invasive surgeries have fueled the growth of the LAI drug delivery market.

7. BD Vystra™ Disposable Pen 6/26/2025

   BD Vystra™ Disposable Pen is a proven, globally adopted drug delivery platform with over 175 million units sold, supporting diverse therapies in 40+ countries.

8. Development Of Next Gen Sustained Release Solutions For Pain Management 2/22/2023

   A TheraPEA™ polymer based injectable formulation designed to deliver the same dose of Triamcinolone Acetonide (TAA) as in Zilretta^® has shown promising results in a series of pre-clinical studies.

9. Using FT-IR To Identify Contaminants In Drug Delivery Systems & Combination Products 3/7/2024

   Learn how formulation, device, quality, and engineering teams can strengthen contamination-control strategies, improve delivery reliability, and reduce product-quality risk throughout the drug-delivery lifecycle.

10. Inspection Of Injectable Products For Visible Particulates 8/8/2023

    Examine the risks posed by particulates, the potential sources and types of particulates, and approaches to detect and measure visible particulates in injectables.